Tilray Brands, Inc. TLRY · NASDAQ
$2.53 -4.17% (-$0.11)
Summary
37 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 20% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 6 times in the last 8 quarters.
- Revenue growth is slowing: 2.7% a year over the last 3 years against 8.1% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.1% a year over 5 years. Over the last 3 years it grew by 2.7% a year. For the next fiscal year analysts expect revenue to grow by 20%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $188.6M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 4
- Hold 14
- Sell 2
Today's price within the analysts' price targets
The average target of $65.01 is 2,470% above today's price. 20% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Cannabis Segment 35%
- Distribution Revenue 32%
- Beverage Alcohol Business 26%
- Wellness Business 6.5%
By region
- EMEA 49%
- UNITED STATES 26%
- CANADA 24%
- Rest of World 1.3%
Cannabis Segment brings in 35% of revenue. Beverage Alcohol Business grew fastest, by 23% a year.
Segments in detail